Jul 1 2010
Vitrolife (STO:VITR):
“The follicle aspiration needle Swemed Sense™ makes it possible to work in a new way, which is more favourable for patients, and at the same time it meets all the other quality requirements for a follicle aspiration needle”
The Swemed Sense™ needle gives less pain and bleeding compared with a conventional needle for oocyte aspiration. The results of the multicenter study carried out in Sweden were presented yesterday during the ongoing ESHRE conference in Rome.
"The follicle aspiration needle Swemed Sense™ makes it possible to work in a new way, which is more favourable for patients, and at the same time it meets all the other quality requirements for a follicle aspiration needle", says Dr. Matts Wikland, who works at Fertility Center Scandinavia in Gothenburg, when he presented the results of the study at the annual meeting of ESHRE, the European Society of Human Reproduction and Embryology. The conference has been ongoing since Sunday and has gathered approximately 8,000 international delegates.
The study has investigated how the sensation of pain in women undergoing oocyte aspiration before IVF differs if a new needle with a thinner tip (Swemed Sense™) is used, compared with a conventional, thicker needle. The results show that a needle with a thinner tip give less pain and bleeding compared with a conventional needle. The time taken to retrieve oocytes and the number of undamaged oocytes were not different in the two groups.
Source Vitrolife AB